Housebuilders dent London's FTSE 100 even as consumer staples gain
Reuters
Published Jan 10, 2022 08:35
Updated Jan 10, 2022 17:05
(Reuters) -UK's blue-chip index ended lower on Monday as housebuilders were hit by $5.4 billion in costs to remove cladding from buildings, while a weaker pound lifted consumer staples.
The FTSE 100 ended 0.5% lower following weekly gains spurred by a rotation into sectors such as banks, oil & gas and mining as investors priced in faster interest rate hikes by major central banks.
Large dollar earners including Diageo (LON:DGE), Unilever (LON:ULVR), British American Tobacco (LON:BATS), Reckitt Benckiser gained between 0.7% and 2%, lifted by the weaker pound.
Berkeley Group, Barratt Developments (LON:BDEV), Persimmon (LON:PSN) and Taylor Wimpey (LON:TW) were down between 3.0% and 2.8% after Britain ordered housebuilders to pay around $5.4 billion to help remove dangerous cladding from buildings following a deadly 2017 London fire.
Housing minister Michael Gove set an early-March deadline for the industry to agree to a fully funded plan of action, including a dedicated fund to deal with unsafe cladding.
"The housebuilders have benefited from generous incentives, such as Help to Buy and the mortgage guarantee scheme, in recent years. However, state support is not a one-way street and the sector needs to do its bit to look after its customers," said Russ Mould, investment director at AJ Bell.
Persimmon had the least risk due to its low exposure, while Barratt, Bellway (LON:BWY), Berkeley & Taylor Wimpey all had the higher risk of a more meaningful step up in provisions, Jefferies analysts said.
Housebuilders Redrow (LON:RDW), Countryside Properties, Bellway and Vistry Group (LON:VTYV) dropped between 2.8% and 4.4%, while the FTSE 250 index slipped 1.5%, recording its fourth consecutive-session in losses.
Big banks such as HSBC, Barclays (LON:BARC) and Standard Chartered (LON:STAN) rose about 1% each, building on last week's gains.
Get The App
Plus500 (LON:PLUSP) rose 3.1% after the online trading platform said it expects annual results to exceed market expectations, even as it reported slower fourth-quarter growth.
Biotech firm Avacta Group slumped 33.4% after it said it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron variant at lower viral loads.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.